Patients should report persistent stool changes to their GP, particularly if accompanied by abdominal pain, as GLP-1 therapy carries rare risks of pancreatitis and gallbladder disease
Bariatric surgeries, like many medical procedures, are known to have declined during the first full year of the covid-19 pandemic in 2020
sustained visceral fat reduction requires ongoing treatment and lifestyle modification Factors influencing response include baseline BMI, adherence to dietary changes, physical activity levels, genetic factors, and concurrent medications
Neurospora Newslett., 16 : 8
Thanks to biochemical engineering, the glucagon-like peptide-1 (GLP-1) molecule has emerged as an essential element in the development of diverse agonists and multiagonists, based in the GLP-1 structure for obesity treatment